Quick Takeaways
- Hexstone Capital LLC filed SCHEDULE 13G/A for Cellectar Biosciences, Inc. Common Stock, par value $0.00001 per share (CLRB).
- Disclosed ownership: 4.9%.
- Date of event: 31 Dec 2025.
Hexstone Capital LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Cellectar Biosciences, Inc. Common Stock, par value $0.00001 per share (CLRB)
- Filing Manager
- Hexstone Capital LLC
- Reporting Manager
- Hexstone Capital LLC
- Symbol
- CLRB
- Shares outstanding
- 4,410,816 shares
- Disclosed Ownership
- 216,130 shares
- Ownership
- 4.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 04 Feb 2026, 16:11:14 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 08 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Hexstone Capital LLC disclosed 4.9% ownership in Cellectar Biosciences, Inc. Common Stock, par value $0.00001 per share (CLRB) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 08 Aug 2025.
- Current filing was accepted on 04 Feb 2026, 16:11.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Hexstone Capital LLC | 4.9% | 216,130 | 0 | 216,130 | /s/ Hexstone Capital LLC | Brendan O'Neil, Managing Member | |
| Brendan O'Neil | 4.9% | 216,130 | 0 | 216,130 | /s/ Brendan O'Neil | Brendan O'Neil |